Volume 66, Issue 6, Pages (December 2014)

Slides:



Advertisements
Similar presentations
Volume 72, Issue 1, Pages (July 2017)
Advertisements

The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 44, Issue 6, Pages (December 2003)
Volume 66, Issue 6, Pages (December 2014)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 58, Issue 1, Pages (July 2010)
Volume 60, Issue 2, Pages (August 2011)
Volume 57, Issue 6, Pages (June 2010)
European Urology Oncology
Volume 61, Issue 5, Pages (May 2012)
Volume 68, Issue 3, Pages (September 2015)
Volume 51, Issue 4, Pages (April 2007)
Volume 51, Issue 3, Pages (March 2007)
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Volume 53, Issue 5, Pages (May 2008)
Volume 70, Issue 2, Pages (August 2016)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Volume 72, Issue 5, Pages (November 2017)
Prostate Cancer Epidemic in Sight?
Volume 61, Issue 4, Pages (April 2012)
Volume 64, Issue 4, Pages (October 2013)
Volume 63, Issue 1, Pages (January 2013)
Volume 64, Issue 4, Pages (October 2013)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 61, Issue 5, Pages (May 2012)
Volume 68, Issue 1, Pages 5-7 (July 2015)
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 64, Issue 5, Pages (November 2013)
Volume 68, Issue 1, Pages (July 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 71, Issue 6, Pages (June 2017)
Volume 64, Issue 4, Pages (October 2013)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 66, Issue 6, Pages (December 2014)
Volume 63, Issue 3, Pages (March 2013)
Volume 62, Issue 4, Pages (October 2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 60, Issue 6, Pages (December 2011)
The Economic Costs of Overactive Bladder in Germany
Volume 53, Issue 1, Pages (January 2008)
Volume 69, Issue 6, Pages (June 2016)
Volume 62, Issue 3, Pages (September 2012)
Volume 70, Issue 2, Pages (August 2016)
Volume 50, Issue 5, Pages (November 2006)
Testicular Cancer Variations in Time and Space in Europe
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
Volume 72, Issue 1, Pages (July 2017)
European Urology is “Your” Journal
Epidemiology of Renal Cell Carcinoma
European Urology Oncology
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 66, Issue 6, Pages 1157-1164 (December 2014) Pretreatment Neutrophil-to-Lymphocyte Ratio Is Associated with Advanced Pathologic Tumor Stage and Increased Cancer-specific Mortality Among Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy  Boyd R. Viers, Stephen A. Boorjian, Igor Frank, Robert F. Tarrell, Prabin Thapa, R. Jeffrey Karnes, R. Houston Thompson, Matthew K. Tollefson  European Urology  Volume 66, Issue 6, Pages 1157-1164 (December 2014) DOI: 10.1016/j.eururo.2014.02.042 Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 1 Difference (Δ) between prior neutrophil-to-lymphocyte ratio (NLR) value and index NLR ≤90 d before radical cystectomy. European Urology 2014 66, 1157-1164DOI: (10.1016/j.eururo.2014.02.042) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 2 Cancer-specific survival following radical cystectomy for bladder cancer, stratified by neutrophil-to-lymphocyte ratio (NLR). European Urology 2014 66, 1157-1164DOI: (10.1016/j.eururo.2014.02.042) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 3 Overall survival following radical cystectomy for bladder cancer, stratified by neutrophil-to-lymphocyte ratio (NLR). European Urology 2014 66, 1157-1164DOI: (10.1016/j.eururo.2014.02.042) Copyright © 2014 European Association of Urology Terms and Conditions

Fig. 4 Neutrophil-to-lymphocyte ratio (NLR) and cancer-specific survival following radical cystectomy for bladder cancer, stratified by pathologic stage: (A) stage ≤pT1; (B) stage pT2; (C) stage pT3/4. European Urology 2014 66, 1157-1164DOI: (10.1016/j.eururo.2014.02.042) Copyright © 2014 European Association of Urology Terms and Conditions